Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease - Concepedia

Concepedia

Publication | Open Access

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease

DOI Full Paper Access

103

Citations

31

References

2018

Year

Motoki Fujimaki, Shinji Saiki, Yuanzhe Li, Naoko Kaga, Hikari Taka, Taku Hatano, Kei‐ichi Ishikawa, Yutaka Oji, Akio Mori, Ayami Okuzumi,

Abstract

This study provides Class III evidence that decreased serum levels of caffeine and its metabolites identify patients with PD.

References

	Year	Citations
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm P. Naresh Kumar, Steven Henikoff, Pauline C. Ng Nature Protocols Protein FunctionFunctional GenomicsNon-synonymous VariantsGene RecognitionGenetics	2009	6.6K
Gut microbiota are related to Parkinson's disease and clinical phenotype Filip Scheperjans, Velma T. E. Aho, Pedro A. B. Pereira, Movement Disorders DysbiosisHost-microbe InteractionsGastroenterologyPathologyGut Microbiota	2014	1.9K
Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Karimollah Hajian‐Tilaki PubMed Curve AnalysisDisease DiagnosisRoc CurveHealth InformaticsHealthy Subjects	2013	1.8K
Colonic bacterial composition in Parkinson's disease Ali Keshavarzian, Stefan J. Green, Phillip A. Engen, Movement Disorders	2015	1.3K
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women Alberto Ascherio, Shumin M. Zhang, Miguel A. Hernán, Annals of Neurology	2001	677
Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Marguerite A. Butler, M. Iwasaki, F. Peter Guengerich, Proceedings of the National Academy of Sciences Metabolomic ProfilingPharmacotherapyCytochrome P-450paToxicological MechanismCarbonyl Metabolism	1989	638
Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. Jiang‐Fan Chen, Kui Xu, Jacobus P. Petzer, PubMed Common ConsumptionNeurotransmitterPharmacotherapySocial SciencesMolecular Pharmacology	2001	509
Neuroprotection by Caffeine and A<sub>2A</sub>Adenosine Receptor Inactivation in a Model of Parkinson's Disease Jiang‐Fan Chen, Kui Xu, Jacobus P. Petzer, Journal of Neuroscience	2001	442
Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition Shinji Saiki, Yukiko Sasazawa, Yoko Imamichi, Autophagy Cell AutophagyMitophagySignal TransductionMolecular PhysiologyCaffeine Induces Apoptosis	2011	417
123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease Satoshi Orimo, Eisuke Ozawa, Soju NAKADE, Journal of Neurology Neurosurgery & Psychiatry	1999	354

Page 1